Landmark Publication Underscores Robust Ability of CytoSorb to Reduce Cytokine Storm during Systemic HyperinflammationGlobeNewsWire • 03/29/23
CytoSorbents Highlights New Clinical Data from Current Studies at the Live 42nd International Symposium on Intensive Care & Emergency Medicine (ISICEM)GlobeNewsWire • 03/22/23
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-TimeGlobeNewsWire • 03/07/23
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 RevenuePRNewsWire • 01/31/23
CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T TrialPRNewsWire • 01/23/23
CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory AffairsPRNewsWire • 01/17/23
CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan AgreementPRNewsWire • 12/29/22
CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without ModificationsPRNewsWire • 12/21/22
CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients EnrolledPRNewsWire • 11/14/22
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. HospitalsPRNewsWire • 11/02/22
National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine PlasmaPRNewsWire • 10/31/22
CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual MeetingPRNewsWire • 10/12/22